Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Palvella Therapeutics (PVLA) vs. Competitors

805 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
PVLAPalvella Therapeutics$145.77$2.13B-26.5050.42%Strong BuyUnlock the PVLA analyst price target with TipRanks PremiumPVLAUnlock the PVLA top-analyst price target with TipRanks Premium
MNPRMonopar Therapeutics Inc$70.29$476.34M-27.24-15.31%Strong BuyUnlock the MNPR analyst price target with TipRanks PremiumPVLA vs MNPRUnlock the MNPR top-analyst price target with TipRanks Premium
NRIXNurix Therapeutics$13.60$1.49B5.42-5.09%Strong BuyUnlock the NRIX analyst price target with TipRanks PremiumPVLA vs NRIXUnlock the NRIX top-analyst price target with TipRanks Premium
TYRATyra Bioscience$19.73$1.36B-7.4718.71%Strong BuyUnlock the TYRA analyst price target with TipRanks PremiumPVLA vs TYRAUnlock the TYRA top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PVLAPalvella Therapeutics145.7754.2359.24%
MNPRMonopar Therapeutics Inc70.29-12.71-15.31%
NRIXNurix Therapeutics13.60-1.73-11.29%
TYRATyra Bioscience19.73-1.27-6.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts